Literature DB >> 2375436

Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships.

W C Sanderson1, A T Beck, J Beck.   

Abstract

The authors administered the Structured Clinical Interview for DSM-III-R to 260 patients with principal diagnoses of depressive disorders. Approximately two-thirds of these patients were given at least one additional concurrent axis I disorder. The most common comorbid diagnoses were anxiety disorders. The depressive disorders preceded the anxiety disorders in most patients. The authors not only point out the scientific and clinical implications of psychiatric comorbidity in view of the patterns of comorbidity found in this and previous studies but also discuss issues in comorbidity research.

Entities:  

Mesh:

Year:  1990        PMID: 2375436     DOI: 10.1176/ajp.147.8.1025

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  18 in total

1.  Managing depression in primary care: achieving remission.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

2.  The impact of panic-agoraphobic comorbidity on suicidality in hospitalized patients with major depression.

Authors:  Lily A Brown; Brandon A Gaudiano; Ivan W Miller
Journal:  Depress Anxiety       Date:  2010-03       Impact factor: 6.505

3.  Subdiagnostic alcohol use by depressed men and women seeking outpatient psychiatric services: consumption patterns and motivation to reduce drinking.

Authors:  Derek D Satre; Felicia W Chi; Stuart Eisendrath; Constance Weisner
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

4.  A study of comorbidity in psychoactive substance dependence patients.

Authors:  P Kisore; N Lal; J K Trivedi; P K Dalal; V M Aga
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

5.  A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.

Authors:  Erica M Richards; Daniel C Mathews; David A Luckenbaugh; Dawn F Ionescu; Rodrigo Machado-Vieira; Mark J Niciu; Wallace C Duncan; Neal M Nolan; Jose A Franco-Chaves; Thomas Hudzik; Carla Maciag; Shuang Li; Alan Cross; Mark A Smith; Carlos A Zarate
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

6.  The potential utility of drinking motive questions to screen at-risk drinking in socially anxious patients.

Authors:  Peter M Miller; Sarah W Book; Suzanne Thomas; Joshua P Smith; Patrick K Randall; Carrie L Randall
Journal:  J Subst Use       Date:  2014-06-01

Review 7.  Neurobiology of anxious depression: a review.

Authors:  Dawn F Ionescu; Mark J Niciu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2013-03-11       Impact factor: 6.505

8.  A clinical study of chronic depression.

Authors:  S Singhal; S Kumar; A K Agarwal
Journal:  Indian J Psychiatry       Date:  1991-10       Impact factor: 1.759

9.  Familiality of major depressive disorder and patterns of lifetime comorbidity. The NEMESIS and GenMood studies. A comparison of three samples.

Authors:  Maaike Verhagen; Annemarie van der Meij; Barbara Franke; Wilma A M Vollebergh; Ron de Graaf; Jan K Buitelaar; Joost G E Janzing
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-24       Impact factor: 5.270

10.  The moderation of an early intervention program for anxiety and depression by specific psychological symptoms.

Authors:  Kelly C Cukrowicz; Phillip N Smith; Holly C Hohmeister; Thomas E Joiner
Journal:  J Clin Psychol       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.